Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Fourth Quarter 2024 and Recent Developments: The Phase 2 Tailwind study represents the second successful clinical trial for AP-PA02, Armata's lead pulmonary candidate, which was first evaluated in ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
Scientists report long-term gantenerumab use might prevent cognitive decline in people with genetic predisposition to ...
THE last thing Lau remembered were the cries of his grade three pupils, shaking him and tapping his legs before he totally ...
Plans for works to “improve the appearance and security” of a regeneration project at a historic Sunderland site have been ...
A theoretical study demonstrates magnetic force lowers blood pressure fluctuations and stabilises flow, setting the stage for ...
To date, Adam has participated in transactions totaling approximately four million square feet of commercial properties, as well as thousands of residential units, hotels and new development land ...